Streamex Corp. · NASDAQ:STEX
Streamex — BioSig Technologies — LD Micro Main Event 2020
8 slides from Streamex's conference presentation, Dec 14, 2020
Slide 1: BioSig Technologies - LD Micro Main Event
BioSig: technologies LD Micro Main Event December 14", 2020 NASDAQ: BSGM
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements including statements that address activities, events or developments that BioSig expects, believes or anticipates will or may occur in the future, such as predictions of financial performance, approvals and launches by BioSig of new pr
Slide 3: Who We Are
Who We Are - NASDAQ: BSGM Er SEE MORE, CLEARLY ¢ EP Tech Market 13.5% CAGR * Global EP Market Expected to be $12.2 Billion by 2026* ¢ 31 Patents Issued ¢ First Customer is #1 Center by Volume in U.S. ¢ Razor & Blade Business Model ¢ FDA Approved ark ltl Beeps Doe Maret SYMBOL: BSGM 3 $12.20 by 2028
Slide 4: Market Opportunity - PURE EP
Market Opportunity - PURE EP ™ Complex Cardiac Ablation: 13.5% Growth Rate 3,425 EP labs Total Global Addressable Market $2.0 Billion
Slide 5: PURE EP System - Customer Installations
PURE EP™ System - Customer Installations ce Z Texas Cardiac Arrhythmia Institute
Slide 6: Commercialization - Regions and Centers of Excellence
Commercialization - Regions and Centers of Excellence ecu ate ane esi Teenrlogies ne estietes. Revenue Potential $286 Million Florida 120 EP Programs 240 Labs Texas 220 EP Programs 440 Labs Northeast 175 EP Programs 400 Labs syMBoL:BscM | 6
Slide 7: Business Model
Business Model Sets Modules Service Agreements Em E, CLEARLY BioSigé ov=sovevaieser cit setessng Dice SYMBOL: BSGM TeMGoetOoudtensi20norby 2020
Slide 8: Value Drivers
Value Drivers * Raised $41 million in 2020 * $32 million in cash on the balance sheet and no debt * Achieved first commercial contract 4Q20 ¢ Expect to triple the customer base in 2021 ¢ CE mark approval / EU entry Q4 2021 * Sequential revenue growth in 2021 jf Nasdaq: BSGM BioSig symBol: scm | 8 ‘e